ERIS LIFESCIENCES
Back to Income Statement
|
ERIS LIFESCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,009 Cr | ₹16,851 Cr | ₹1,347 Cr | ₹1,212 Cr | ₹1,074 Cr |
What is the latest Revenue of ERIS LIFESCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,009 Cr |
| Mar2024 | ₹16,851 Cr |
| Mar2023 | ₹1,347 Cr |
| Mar2022 | ₹1,212 Cr |
| Mar2021 | ₹1,074 Cr |
How is Revenue of ERIS LIFESCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,009 Cr | -88.08 | |
| Mar2024 | ₹16,851 Cr | 1,151.00 | |
| Mar2023 | ₹1,347 Cr | 11.15 | |
| Mar2022 | ₹1,212 Cr | 12.83 | |
| Mar2021 | ₹1,074 Cr | - | |
Compare Revenue of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹19,224.5 Cr | 5.4% | 2.8% | 3.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 5.4% |
2.8% |
3.8% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses